Erratum to: Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients (The Journal of Clinical Pharmacology, (2015), 55, 3, (279-287), 10.1002/jcph.408);Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients

Journal of Clinical Pharmacology

Volumn 55, Issue 3, 2015, Pages 279-287

  Wong, Martin C S ^a   Wu, Carmen H M ^b   Wang, Harry H X ^a,c   Li, Heung Wing ^b   Hui, Eric M T ^b   Lam, Augustine T ^b   Chung, Roger Y N ^a   Yip, Benjamin H K ^a   Morisky, Donald E ^d  

^a Prince of Wales Hospital   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

associated factors; glycaemic control; MMAS 8; Morisky Medication Adherence Scale; oral hypoglycaemic agents; primary care

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CHINESE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DRUG USE; FEMALE; GLYCEMIC CONTROL; HONG KONG; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MORISKY MEDICATION ADHERENCE SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCORING SYSTEM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; BLOOD; CHINA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ETHNOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PSYCHOLOGY; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926069274     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.992     Document Type: Erratum

References (45)

1. Danaei G, Finucane MM, Lu Y, et al., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378 (9785): 31-40.
2. Lipscombe LL, Hux JE,. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007; 369 (9563): 750-756.
3. Sloan FA, Bethel MA, Ruiz D Jr., Shea AM, Feinglos MN,. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008; 168 (2): 192-199; discussion 199.
4. Wang HHX, Wang JJ, Wong SYS, et al., Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China. BMC Med. 2014; 12: 188. doi: 10.1186/s12916-014-0188-0.
5. Hu G, Sarti C, Jousilahti P, et al., The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke. 2005; 36 (12): 2538-2543.
6. Saydah S, Tao M, Imperatore G, Gregg E,. GHb level and subsequent mortality among adults in the US. Diabetes Care. 2009; 32 (8): 1440-1446.
7. Wong MCS, Wang HHX, Cheung CSK, et al., Factors associated with multimorbidity and its link with poor blood pressure control among 223,286 hypertensive patients. Int J Cardiol. 2014; 177 (1): 202-208.
8. Diabetes Fact Sheet. World Health Organization; 2011.
9. Chan NN, Kong AP, Chan JC,. Metabolic syndrome and type 2 diabetes: the Hong Kong perspective. Clin Biochem Rev/Australian Assoc Clin Biochem. 2005; 26 (3): 51-57.
10. Wong MCS, Wang HHX, Kwan MWM, et al., Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review. Plos One. 2014; 9 (3): e90963.
11. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T,. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adher. 2013; 7: 525-530.
12. Lee VW, Leung PY,. Lycemic control and medication compliance in diabetic patients in a pharmacist-managed clinic in Hong Kong. Am J Health-Sys Pharm. 2003; 60 (24): 2593-2596.
13. Schectman JM, Nadkarni MM, Voss JD,. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002; 25 (6): 1015-1021.
14. Bezie Y, Molina M, Hernandez N, Batista R, Niang S, Huet D,. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006; 32 (6): 611-616.
15. Vik SA, Maxwell C, Hogan D,. Determinants and Health Related Outcomes Associated with Nonadherence to Prescribed Drug Regimens: A Comparison of Rural and Urban Home Care Clients. Edmonton: Institute of Health Economics; 2003.
16. Vik SA, Maxwell CJ, Hogan DB,. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004; 38 (2): 303-312.
17. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J,. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980; 2 (6): 757-764.
18. Shalansky SJ, Levy AR, Ignaszewski AP,. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004; 38 (9): 1363-1368.
19. Wong MCS, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW,. Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. Bmc Health Serv Res. 2008; 8: 138.
20. Wong MCS, Jiang JY, Griffiths SM,. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Clin Ther. 2009; 31 (10): 2170-2177.
21. Wong MCS, Jiang JY, Griffiths SM,. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens. 2009; 22 (8): 904-910.
22. Wong MCS, Jiang JY, Griffiths SM,. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol. 2010; 50 (5): 598-605.
23. Wong MCS, Jiang JY, Griffiths SM,. Adherence to combination therapy among ethnic Chinese patients: a cohort study. Hypertens Res. 2010; 33 (5): 416-421.
24. Wong MCS, Jiang JY, Griffiths SM,. Factors associated with compliance to thiazide diuretics among 8551 Chinese patients. J Clin Pharm Ther. 2011; 36 (2): 179-186.
25. Wong MCS, Tam WWS, Cheung CSK, et al., Medication adherence to first-line antihypertensive drug class in a large Chinese population. Int J Cardiol. 2013; 167 (4): 1438-1442.
26. Wong MCS, Tam WWS, Cheung CSK, et al., Antihypertensive prescriptions over a 10-year period in a large Chinese population. Am J Hypertens. 2013; 26 (7): 931-938.
27. Wong MCS, Tam WWS, Cheung CSK, et al., Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study. Int J Cardiol. 2013; 168 (2): 928-933.
28. Wong MCS, Tam WWS, Wang HHX, et al., Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study. Int J Cardiol. 2013; 168 (5): 4705-4710.
29. 2011 Hong Kong Population Census. http://www.census2011.gov.hk/en/index.html. Accessed October 25, 2014.
30. Lee GKY, Wang HHX, Liu KQL, Cheung Y, Morisky DE, Wong MCS,. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. Plos One. 2013; 8 (4): e62775.
31. Wong MCS, Liu KQL, Wang HHX, et al., Effectiveness of a pharmacist-led drug counseling on enhancing antihypertensive adherence and blood pressure control: a randomized controlled trial. J Clin Pharmacol. 2013; 53 (7): 753-761.
32. Tzeng JI, Chang CC, Chang HJ, Lin CC,. Assessing analgesic regimen adherence with the Morisky Medication Adherence Measure for Taiwanese patients with cancer pain. J Pain Symptom Manag. 2008; 36 (2): 157-166.
33. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE,. The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010; 90 (2): 216-221.
34. Sakthong P, Chabunthom R, Charoenvisuthiwongs R,. Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother. 2009; 43 (5): 950-957.
35. Zhang SY, Bai LQ, Tan HZ, Yang HL,. Application of the Morisky medication adherence scale on pulmonary tuberculosis patients. Chin J Antituberculosis. 2010; 32 (9): 527-530.
36. Wu CHM, Wong MCS, Wang HHX, et al., The eight-item Morisky medication adherence scale (MMAS-8) score was associated with glycaemic control in diabetes patients. Paper presented at: American Heart Association High Blood Pressure Research 2014 Scientific Sessions; September 2014; San Francisco, CA.
37. Morisky DE, Green LW, Levine DM,. Concurrent and predictive-validity of a self-reported measure of medication adherence. Med Care. 1986; 24 (1): 67-74.
38. Morisky DE, Ang A, Krousel-Wood M, Ward HJ,. Predictive validity of a Medication Adherence Measure in an outpatient setting. J Clin Hypertens. 2008; 10 (5): 348-354.
39. Bassett J, Organization WH,. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment: Australia: Health Communications; 2000.
40. Wong MCS, Kong APS, So WY, et al., Pharmacoepidemiological profiles of oral hypoglycemic agents among 28,773 Chinese patients with diabetes. Diabetes Res Clin Pract. 2012; 96 (3): 319-325.
41. Twinn SF, Lee GC, Thompson DR,. A survey of lifestyle risk factors for cardiovascular health among young Hong Kong Chinese women: implications for long-term cardiovascular health. J Women's Health. 2010; 19 (2): 289-295.
42. Raosoft sample size calculator. http://www.raosoft.com/samplesize.html. Accessed October 25, 2014.
43. Raum E, Kramer HU, Ruter G, et al., Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012; 97 (3): 377-384.
44. Wong MCS, Kong APS, So WY, Jiang JY, Chan JCN, Griffiths SM,. Adherence to oral hypoglycemic agents in 26 782 Chinese patients: a cohort study. J Clin Pharmacol. 2011; 51 (10): 1474-1482.
45. Al-Qazaz H, Sulaiman SA, Hassali MA, et al., Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011; 33 (6): 1028-1035.